A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease
Coronary Disease, Ischemic Heart Disease, Heart Failure
About this trial
This is an interventional treatment trial for Coronary Disease focused on measuring coronary disease, heart failure, quality improvement, knowledge translation, opinion leaders
Eligibility Criteria
Inclusion Criteria: Patients with HF or IHD who are not currently taking the study medications of interest (ACE inhibitors/angiotensin receptor blockers for HF or statins for IHD) and whose primary care physicians are part of the study population Exclusion Criteria: Patients who are unable or unwilling to give informed consent, previously taken the study medications according to dispensing records allergy or intolerance to study medications residents of long-term care facilities unable to confirm a diagnosis of either HF or IHD primary care physician has already contributed 5 patients to the study
Sites / Locations
- University of Alberta